跳至主要内容
临床试验/EUCTR2006-005889-40-NL
EUCTR2006-005889-40-NL进行中(未招募)不适用

Acetylcysteine for Treatment of Sickle Cell Disease - N-acetylcystein for Sickle Cell Disease

Academic Medical Centre0 个研究点目标入组 10 人开始时间: 2006年11月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Ten patients with SCD (HbSS HbSC or HbSb) will be included.
  • Inclusion criteria
  • 1.High performance liquid chromatography confirmed diagnosis of HbSS HbSC or HbSb genotype
  • 2.Aged 18-65 years
  • 3.Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • 1.Bloodtransfusion in the preceding four months
  • 2.Pregnancy or the desire to get pregnant in the following 7 months
  • 3.Concommitant use of hydroxyurea, vitamin K antagonists or other oral anticoagulants, or contraindications for NAC.
  • 4.Impaired renal function of more than 60% (as assessed by the Kockroft-Gauld equation)
  • 5.Known gatsric or duodenal ulcer
  • 6.Concomittant use of anti-hypertensives, sildefanil or nitrates.

研究者

发起方
Academic Medical Centre

相似试验